Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma

被引：11
|
作者：
Uchiyama, Michihiro [1 ]
Tamai, Yotaro [1 ]
Ikeda, Takashi [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Hematol & Stem Cell Transplantat, Nagaizumi, Shizuoka 4118777, Japan
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2010年 / 14卷 / 03期
关键词：
LAMIVUDINE THERAPY;
D O I：
10.1016/j.ijid.2009.04.014
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E265 / E266
页数：2
相关论文
共 50 条
  • [1] Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
    Shigeru Kusumoto
    Yasuhito Tanaka
    Masashi Mizokami
    Ryuzo Ueda
    International Journal of Hematology, 2009, 90 : 13 - 23
  • [2] Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma
    Kusumoto, Shigeru
    Tanaka, Yasuhito
    Mizokami, Masashi
    Ueda, Ryuzo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (01) : 13 - 23
  • [3] Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
    Huang, Yi-Hsiang
    Hsiao, Liang-Tsai
    Hong, Ying-Chung
    Chiou, Tzeon-Jye
    Yu, Yuan-Bin
    Gau, Jyh-Pyng
    Liu, Chun-Yu
    Yang, Muh-Hwa
    Tzeng, Cheng-Hwai
    Lee, Pui-Ching
    Lin, Han-Chieh
    Lee, Shou-Dong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) : 2765 - +
  • [4] Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine
    Simpson, ND
    Simpson, PW
    Ahmed, AM
    Nguyen, MH
    Garcia, G
    Keeffe, EB
    Ahmed, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (01) : 68 - 71
  • [5] A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
    Chen, Wen-Chi
    Cheng, Jin-Shiung
    Chiang, Po-Hung
    Tsay, Feng-Woei
    Chan, Hoi-Hung
    Chang, Hsueh-Wen
    Yu, Hsien-Chung
    Tsai, Wei-Lun
    Lai, Kwok-Hung
    Hsu, Ping-I
    PLOS ONE, 2015, 10 (06):
  • [6] Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy
    Li, H. -R.
    Huang, J. -J.
    Guo, H. -Q.
    Zhang, X.
    Xie, Y.
    Zhu, H. -L.
    Zhai, L. -Z.
    Pu, X. -X.
    Huang, Y.
    Guo, C. -C.
    Lin, T. -Y.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (12) : 877 - 883
  • [7] Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab
    Pei, Sung-Nan
    Chen, Chien-Hung
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1611 - 1618
  • [8] Hepatitis B virus reactivation in a case of Non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy
    Tsutsumi, Y
    Kawamura, T
    Saitoh, S
    Yamada, M
    Obara, S
    Miura, T
    Kanamori, H
    Tanaka, J
    Asaka, M
    Imamura, M
    Masauzi, N
    LEUKEMIA & LYMPHOMA, 2004, 45 (03) : 627 - 629
  • [9] Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy
    Cao, Wenyue
    Wei, Jia
    Wang, Na
    Xu, Hao
    Xiao, Min
    Huang, Lifang
    Cao, Yang
    Li, Chunrui
    Xiao, Yi
    Gu, Chaojiang
    Zhang, Shangkun
    Li, Dengju
    Zhang, Yichen
    Zhang, Tongcun
    Zhou, Jianfeng
    Huang, Liang
    BLOOD, 2020, 136 (04) : 516 - 519
  • [10] Clinical features of lymphoma chemotherapy associated hepatitis virus B reactivation
    Shi, Dongmei
    Xie, Qing
    Gui, Honglian
    Wang, Hui
    Jia, Nina
    HEPATOLOGY, 2007, 46 (04) : 684A - 684A
12345